MacroGenics
MGNX
157 hedge funds and large institutions have $795M invested in MacroGenics in 2019 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 61 increasing their positions, 37 reducing their positions, and 14 closing their positions.
223% more call options, than puts
Call options by funds: $6.85M | Put options by funds: $2.12M
179% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 14
70% more capital invested
Capital invested by funds: $467M → $795M (+$328M)
65% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 37
18% more funds holding
Funds holding: 133 → 157 (+24)
3.54% more ownership
Funds ownership: 87.05% → 90.6% (+3.5%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$21.9M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$19M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$18.4M |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$13.2M |
| 5 |
D.E. Shaw & Co
New York
|
+$11.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$28.6M |
| 2 |
CP
CPV Partners
Stamford,
Connecticut
|
-$13.8M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.73M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$4.78M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.01M |
MGNX Hedge Fund Activity: Q1 2019 in Review
157 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2019, worth a combined $795M — up 70% from $467M a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new MGNX positions and 14 closed out — a net gain of 25 holders — while 61 added to existing stakes and 37 trimmed.
The largest buyer was Millennium Management, adding an estimated $21.9M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $28.6M sold.
- 157 institutional investors held MacroGenics (MGNX) as of Q1 2019, up from 133 in Q4 2018.
- Funds reported $795M of MacroGenics stock for Q1 2019, up 70% quarter-over-quarter.
- 39 funds opened new MacroGenics positions in Q1 2019 and 14 closed out, a net change of +25 holders.
- The largest MacroGenics buyer in Q1 2019 was Millennium Management, an estimated $21.9M added.
- The largest MacroGenics seller in Q1 2019 was T. Rowe Price Associates, an estimated $28.6M sold.
Based on aggregated 13F filings for Q1 2019.